Position in MEDP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$626,167
-$757,176 QoQ
Shares Held
1,304
-47.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026NOMURA HOLDINGS INC holds $19,811,306 across 11 Diagnostics & Research names. MEDP ranks #8 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
60,836 | $12,166,591 | |
| 2 | QGEN |
Qiagen N.V.
|
44,839 | $1,795,353 | |
| 3 | DGX |
Quest Diagnostics Inc
|
5,382 | $1,054,764 | |
| 4 | CSTL |
Castle Biosciences Inc
|
35,748 | $877,613 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
4,550 | $784,875 | |
| 6 | BLLN |
BillionToOne, Inc.
|
8,600 | $678,884 | |
| 7 | TMO |
Thermo Fisher Scientific Inc.
|
1,274 | $626,209 | |
| 8 | MEDP |
Medpace Holdings, Inc.
This page
|
1,304 | $626,167 |
All Filings in MEDP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $626,167 | 1,304 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,383,343 | 2,463 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $740,390 | 1,440 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $408,331 | 1,301 | Shares | Defined | 2025-08-18 | |
| 2024-12-31 | $1,123,601 | 3,382 | Shares | Defined | 2025-02-14 | |
| 2021-03-31 | $984,300 | 6,000 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||